Preparing for the Tsunami of Genomic Data
NGS has triggered a tidal wave of genomic data, whose footprint has rapidly expanded beyond the capacity of our existing storage. Storing and handling big data has become a critical bottleneck in the development of genomic medicine.
In partnership with data optimisation and compression experts Geneformics, we will explore the challenges and opportunities of these giant datasets, and the options available to make giant data more manageable. In this webinar we will cover best practices in building infrastructure that will allow scale up and harness the huge amounts of data in an effective and economic way.
Curious on how the world of big data is changing?
Rafael Feitelberg | Geneformics
Before joining Geneformics, Rafael was Senior Director of Go-to-market and Strategic Marketing at SanDisk. Earlier in his career he was co-founder and CEO of Gilian Technologies, a leading provider of web application security, which is now part of Trustwave.
Eran Segal, PhD | Weizmann Institute of Science
Professor, Department of Computer Science and Applied Mathematics
At the Weizmann Institute, Eran heads a lab with a multi-disciplinary team of computational biologists and experimental scientists in the area of Computational and Systems biology. His group has extensive experience in machine learning, computational biology, probabilistic models, and analysis of heterogeneous high-throughput genomic data. His research focuses on Nutrition, Genetics, Microbiome, and Gene Regulation and their effect on health and disease. His aim is to develop personalized nutrition and personalized medicine.
Hakon Gudbjartsson, PhD | WuXiNextCODE
Dr. Gudbjartsson has over 35 years experience in software development. At deCODE genetics he directed the launch of the first web-based personal genomics service, deCODEme, and was also the lead architect and developer of many software systems including a patient identity protection system, a system for patient cohort definitions and reporting based on a novel Set Definition Langugage (SDL), and a highly scalable database system (GORdb) based on a genomic ordered architecture and a novel query syntax.
Dr. Gudbjartsson received his B.Sc. in electrical engineering in 1990 from the University of Iceland and his M.Sc. in electrical engineering and computer science from MIT in 1992. In 1996, he received his PhD from the Massachusetts Institute of Technology and performed post-doctoral research concerning magnetic resonance imaging at Brigham and Women’s Hospital in Boston until joining deCODE genetics.
Edward Farmer, PhD | WuXiNextCODE
EVP, COMMUNICATIONS & NEW VENTURES
A historian by training, he worked as a television and print journalist and macroeconomic analyst in Mexico City before moving to Reykjavik to join deCODE genetics in the year 2000. As Chief Communications Officer Edward helped to build deCODE’s profile as a global leader in human genetics, overseeing media and investor relations, and launching major websites on gene discovery, DNA-based diagnostics, and drug discovery & development.
Dr. Farmer brings to WuXi NextCODE this first-hand knowledge of the unique approach, assets and scale, on which our technology was developed. Before joining WuXi NextCODE, he was Communications Director for DataMarket, the open and enterprise data visualization startup, and developed a national green energy marketing strategy for Iceland. He holds a BA in political science from Columbia, a diploma in Spanish from the University of Barcelona and did his doctoral work in Mexican history at Trinity College, Cambridge.
Geneformics was founded based on a conviction and a vision:
We are convinced that genomics is the future of medicine, representing an even bigger step forward in human endeavor than the Internet. This means opportunities – and challenges – on the largest possible scale.
Our vision is to be a leader in creating the global-scale Information Technology infrastructure that will be needed for genomics to affect the life of every human on the planet.
To make it all happen, we brought together a stellar team of contributors from the IT and genomics worlds, with backing from first-class investors, all sharing the conviction and committed to the vision – building the genomics Internet.